Biomarker ID 2483 |
| Detailed information | |
|---|---|
| CancerLivER ID | 2483 |
| Biomarker | MYO1D, EST, PDGF-B, LOC113246, SPTAN1, MGC19556, IL6R, PRPSAP1, PDCD6IP, AHNAK, BCL2L11, GPAA1, c-fos, SLC11A2, LOC51235, PRPF8, CD36L1, KIAA1055, HNRPDL, NDRG1, NARS, PABPC4, RDBP, CALM2, PDCD6, C1R, ALB, MT1G, CED-6, AMACR, A2M, FGG, SUPV3L1, PHLDA1, NBP, HAMP, HCS, KIAA0635, ECHS1, SHMT1, NNMT, A |
| Biomarker Name/Symbol (given in Publication) | 61 genes signature (MYO1D, EST, PDGF-B, LOC113246, SPTAN1, MGC19556, IL6R, PRPSAP1, PDCD6IP, AHNAK, BCL2L11, GPAA1, c-fos, SLC11A2, LOC51235, PRPF8, CD36L1, KIAA1055, HNRPDL, NDRG1, NARS, PABPC4, RDBP, CALM2, PDCD6, C1R, ALB, MT1G, CED-6, AMACR, A2M, FGG, SUPV3L1, PHLDA1, NBP, HAMP, HCS, KIAA0635, ECHS1, SHMT1, NNMT, A1BG, ZNF297B, MAWBP, BCL2L1, FGB, HABP2, SLC6A5, SEMA5A, PROL2, EST, GRLF1, LABH3, AQP3, STATI2, p21, IGFBP3, FABP1, STK39, CP, DVL1) |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential Diagnostic marker for HCC and validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Differentially expressed between HCC and non-tumor liver tissue |
| Level of significance | p < 0.01 |
| Source | Tissue |
| PMID | 14642619 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | Training dataset: 68 non-B, non-C liver samples, including 20 T and 17 NT samples, that were obtained from non-B, non-C HCC patients, and 31 N samples from metastatic liver cancer patients; Validation dataset: 37 non-B, non-C liver tissues (20 HCC, 17 non-tumor liver) from 20 patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | 90.00% |
| AUC | |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2003 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |